Get started
Author

Juan L. Trincado

Observed names: J L Trincado, JL Trincado, Juan L Trincado, Juan Luis Trincado, Juan Trincado, Trincado, Juan, Trincado, Juan L, Trincado, Juan L., Trincado, Juan Luis
Observed institutions: Universitat Pompeu Fabra, Universidad de Salamanca, Instituto de Salud Carlos III, Josep Carreras Leukaemia Research Institute, Almirall (Spain), Hospital Del Mar, Barcelona Institute of Science and Technology, Instituto de Investigación Biomédica de Salamanca, Municipal Institute for Medical Research, Centre for Genomic Regulation, Centro de Investigación del Cáncer, Centro Nacional de Análisis Genómico, Hospital del Mar Research Institute, Centro de Investigación Biomédica en Red de Cáncer, Instituto de Biología Molecular y Celular del Cáncer de Salamanca, Universitat de Barcelona
ORCID: 0000-0001-5363-3774
Observed ORCID: 0000-0001-5363-3774
OpenAlex ID: A5073734734
SUPPA2: fast, accurate, and uncertainty-aware differential splicing analysis across multiple conditions
2018 · Juan L. Trincado, Juan C. Entizne, et al. · Genome biology · 706
PDF
Leveraging transcript quantification for fast computation of alternative splicing profiles
2015 · Gael P. Alamancos, Amadís Pagès, et al. · RNA · 277
PDF
A single-cell tumor immune atlas for precision oncology
2021 · Paula Nieto, Marc Elosua-Bayes, et al. · Genome Research · 171
PDF
Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment
2021 · Carlota Rubio-Perez, Ester Planas-Rigol, et al. · Nature Communications · 87
PDF
The prognostic potential of alternative transcript isoforms across human tumors
2016 · Juan L. Trincado, E. Sebestyén, et al. · Genome Medicine · 51
PDF
CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies
2022 · Clara Bueno, Susana Barrera, et al. · Blood · 39
A Single-Cell Tumor Immune Atlas for Precision Oncology
2020 · Paula Nieto, Marc Elosua-Bayes, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 30
PDF
Impaired Condensin Complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL
2020 · Oscar Molina, Meritxell Vinyoles, et al. · Blood · 24
Converging and evolving immuno-genomic routes toward immune escape in breast cancer
2024 · Juan Blanco-Heredia, Carla Anjos Souza, et al. · Nature Communications · 22
PDF
GPRC5C drives branched-chain amino acid metabolism in leukemogenesis
2023 · Yu Wei Zhang, Talia Velasco-Hernandez, et al. · Blood Advances · 20
PDF
Genome Sequencing and RNA-Motif Analysis Reveal Novel Damaging Noncoding Mutations in Human Tumors
2018 · Babita Singh, Juan L. Trincado, et al. · Molecular Cancer Research · 19
PDF
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression
2024 · Belén Lopez-Millan, Alba Rubio-Gayarre, et al. · Blood · 17
Integrative single-cell multi-omics of CD19-CARpos and CARneg T cells suggest drivers of immunotherapy response in B cell neoplasias
2024 · Mercedes Guerrero-Murillo, Aina Rill-Hinarejos, et al. · Cell Reports Medicine · 14
HDAC7 is a major contributor in the pathogenesis of infant t(4;11) proB acute lymphoblastic leukemia
2020 · Oriol de Barrios, Alexandros Galaras, et al. · Leukemia · 14
Integrative single‐cell expression and functional studies unravels a sensitization to cytarabine‐based chemotherapy through HIF pathway inhibition in AML leukemia stem cells
2024 · Talia Velasco‐Hernandez, Juan L. Trincado, et al. · HemaSphere · 13
Formation of an invasion-permissive matrix requires TGFβ/SNAIL1-regulated alternative splicing of fibronectin
2023 · Héctor Franco-Valls, Elsa Tusquets-Uxó, et al. · Breast Cancer Research · 12
PDF
β‐Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T‐cell acute lymphoblastic leukemia
2023 · Violeta García‐Hernández, David Arambilet, et al. · EMBO Molecular Medicine · 12
Leveraging transcript quantification for fast computation of alternative splicing profiles
2014 · Gael P Alamancos, Amadís Pagès, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 12
PDF
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high‐hyperdiploid B‐cell acute lymphoblastic leukemia
2022 · Mireia Ramos‐Muntada, Juan L. Trincado, et al. · Molecular Oncology · 10
PDF
ISOTOPE: ISOform-guided prediction of epiTOPEs in cancer
2021 · Juan L. Trincado, Marina Reixachs-Sole, et al. · PLoS Computational Biology · 8
PDF
Characterisation and Profiling of Standard Atopic Dermatitis Therapies in a Chronic Dermatitis Murine Model Induced by Oxazolone
2024 · Elena Calama, Ana I. Blanco, et al. · Experimental Dermatology · 4
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression
2023 · Oscar Molina, Carmen Ortega-Sabater, et al. · EMBO Molecular Medicine · 4
Integrative single-cell multi-omics of CD19-CARpos and CARneg T cells suggest drivers of immunotherapy response in B cell neoplasias
2025 · Mercedes Guerrero-Murillo, Aina Rill-Hinarejos, et al. · Cell Reports Medicine · 3
Identification of novel small molecule-based strategies of COL7A1 upregulation and readthrough activity for the treatment of recessive dystrophic epidermolysis bullosa
2024 · Irene Jover, Maria C. Ramos, et al. · Scientific Reports · 3
PDF
Author response for "Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia"
2022 · Ramos-Muntada, Mireia, Trincado, Juan L., et al. · 2
Works count: 63
Citation count: 1,578
H-index: 14
I10-index: 19
Year
Topic
Type